The authors found that CD133 stabilized DNA methyltransferases (DNMT) activity via the regulation of DNA (cytosine-5)-methyltransferase 3 beta (DNMT3B) expression in several hepatocellular carcinoma cells [201]. This evidence concerns the gene DNMT3B and hepatocellular carcinoma.